Primary Empty Sella Syndrome in a Woman with Metabolic Syndrome Presenting with Syncopal Attack: A Case Report by Musa, E. et al.
536
Nigerian Journal of Medicine, Vol. 28 No. 4 October - December 2019 ISSBN 1115-2613
Case Report
Primary Empty Sella Syndrome in a Woman with Metabolic 
Syndrome Presenting with Syncopal Attack: A Case Report
1, 2 3  4 4
E. Musa  , B. Alonge , D. Shok , W. Stephen 
1
Division of Endocrinology and Diabetic Medicine, Department of Medicine, University of
Cape Town, Cape Town, South Africa.
2
Department of Internal Medicine, Kaduna State University/BarauDikko Teaching
Hospital, Kaduna, Nigeria.
3
Medical Center, NNPC, Kaduna, Nigeria.
4
Department of Internal Medicine, BarauDikko Teaching Hospital, Kaduna, Nigeria.
ABSTRACT
Background: Empty sella syndrome (ESS) is a disorder that is characterised by leakage of cerebrospinal fluid (CSF) in the 
sella turcica through a diaphragmatic sellae defect, leading to compression and flattening of the pituitary gland. It is 
usually asymptomatic and mostly incidentally detected during neuroimaging for other conditions. There is no data 
reporting a case of primary ESS in a woman with metabolic syndromepresenting with syncopal attack.
Case report: A 62-year old, postmenopausal woman with metabolic syndrome, presented to our Endocrine clinic with 
the history of recurrent syncopal attack for the past 13 years and associated early morning headache and later diagnosed 
with primary empty sella syndrome.
Conclusion: Primary empty sella syndrome should be keenly investigated for with high index of suspicion in women with 
metabolic syndrome presenting with syncopal attack and headache.
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mpty sella syndrome (ESS) is a 
d i s o r d e r  t h a t  i s  a s s o c i a t e d  Ewitharachnoid herniation through a 
diaphragmatic sellae defect with leakage of 
cerebrospinal fluid in the sella turcica, 
leading to compression and flattening of the 
pituitary gland. Most cases of ESS are 
idiopathic.
E m p t y  s e l l a  s y n d r o m e  i s  o f t e n  
asymptomatic and detected incidentally on 
pituitary neuroimaging for other disease 
conditions. Rarely, it presents with 
hormonal deficiencies, giddiness, vomiting, 
v i s u a l  s y m p t o m s  a n d  p e r s i s t e n t  
headache.Vikrant Ghatnatti et al reported 
hormonal deficiencies in about 50% of 
patients diagnosed with primary ESS in 
their case series with hyperprolactinaemia 
as the commonest endocrine abnormality 
whereas De Marinis and colleagues 
reported 19% incidence of endocrine 
abnormality in patients with primary ESS. 
Secondary ESS is usually caused by 
pituitary haemorrhage, infarction or 
surgery, radiation therapy, intracranial 
infections, autoimmune disorders and head 
injury.
Case Report
History: A 62-year old, female retired nurse 
with metabolic syndrome (obesity, 
hypertension, and impaired glucose 
tolerance), presented to our Endocrine clinic 
with the history of recurrent syncope for the 
INTRODUCTION
Correspondence to: Dr. E. Musa 
Department of Internal Medicine
College of Medicine, Kaduna State University, 
Kaduna State - Nigeria
E-mail: ezemusa2000@gmail.com
537
Nigerian Journal of Medicine, Vol. 28 No. 4 October - December 2019 ISSBN 1115-2613
past 13 years with associated early morning 
headache. There was no associated 
vomiting, altered sensorium, personality 
change, and she was not known to be 
epileptic. No history suggestive of adrenal 
insufficiency, cardiac decompensation or 
gastrointestinal tract bleeding. She has 
never had trauma to the brain, pituitary 
surgery or radiation therapy prior to 
presentation. The patientwason lisinopril 
2.5 mg daily and amlodipine 5 mg dailyfor 
her blood pressure control for the last 10 
years.  
Physical examination: She was morbidly 
2
obese (Body Mass Index = 40.8 kg/m ). The 
pulse rate was normal and there was 
elevated blood pressure (BP) but no 
postural hypotension (BP – 140/100 mmHg 
sitting position, 150/100 mmHg standing 
position). There was no  neurologic deficit 
andno peripheral features of Addison's 
disease.
Investigations: She had low serum cortisol 
levels (179.3 nmol/L) (random samples), 
sodium – 142 mmol/L, potassium – 4.0 
mmol/L, bicarbonate – 25 mmol/L, urea – 
3.8 mmol/L, and creatinine – 51 µmol/L. 
Her lipid profile includedtotal cholesterol- 
5.9 mmol/L (hypercholesterolaemia), low-
density lipoprotein cholesterol – 4.85 
mmol/L, triglycerides – 0.6 mmol/L, high-
density lipoprotein cholesterol – 1.36 
mmol/L) and glycated haemoglobin was 
6.2%. The packed cell volume -38%, mean 
c o r p u s c u l a r  v o l u m e  - 8 1 f l ,  m e a n  
corpuscular haemoglobin - 27pg, mean 
corpuscular haemoglobin concentration - 
33g/dl, and stool occult blood was negative.
Oesophagogastroscopy showed foamy 
gastric  juice and antral  gastri t is .  
Echocardiogram reported concentric 
remodeling and grade 1 diastolic 
dysfunction and focal slow waves were seen 
on an electroencephalogram (EEG).
The magnetic resonance imaging (MRI) of 
the brain showed empty pituitary fossa with 
the presence of cerebrospinal fluid intensity 
on all sequences and a centrally placed 
infundibulum (Infundibular sign) (figure 
1). 
Figure 1. MRI Brain (T1 sagittal view) 
showing empty pituitary fossa and 
hypointensity in the region of pituitary 
fossa suggestive of CSF in the sella.
These findings were suggestive of primary 
empty sella syndrome in a patient with 
metabolic syndrome presenting with 
syncopal attacks.
Treatment: She was commenced on 
atorvastatin 20 mg nocte, metformin 500 mg 
twice daily, and clopidogrel 75 mg daily. 
She was counseled on lifestyle modification 
for weight and metabolic control. She 
remained clinically stable following the 
commencement of these medications and 
lifestyle modification.
Discussion
Primary empty sella syndrome is 
characterised by arachnoid herniation 
through a disruption in the diaphragmatic 
sellaewith eventual flattening of the 
pituitary gland.Studies have reported the 
prevalence of primary empty sella 
syndrome to be 8-35% in the general 
p o p u l a t i o n  w i t h  a  5 : 1  f e m a l e  
preponderance. However, a reported 
prevalence of 5.5-12% was found at autopsy 
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and an incidence of 12% of cases by pituitary 
neuroimaging. Primary ESS is commonly 
seen in middle-aged women with obesity 
and hypertension. Ghatnatti et al reported 
that obesity is commoner in Primary ESS 
compared to secondary ESS while Kesler et 
al, reported that 70-80% of primary ESS case 
series were females who had obesity and 
hypertension. In this report, our patient was 
middle-aged,  morbidly obese and 
hypertensive which is in keeping with the 
l i terature.  A commonly proposed 
mechanism explaining the development of 
empty sella syndrome is obstructive sleep 
apnoea-associated hypercapnoea, a 
frequent complication of obesity which 
r e s u l t s  t o  a  r i s e  i n  i n t r a c r a n i a l  
pressure.Also, Sinclair et al proposed that 
obesity can upregulate 11â-HSD1 an 
enzyme that stimulates cortisol synthesis by 
direct effect or through the elaboration of 
adipokines. This leads to hypercortisolism, 
a condition that causes intracranial 
hypertension via overproduction of 
cerebrospinal fluid (CSF) and diminished 
clearance of CSF.Morbid obesity is a likely 
predisposing factor for primary ESS in our 
patient.
Rarely, primary ESS presents with 
hormonal deficiency, but it is most 
commonly associated with headache, 
menstrual irregularities, galactorrhoea, and 
hirsutismas the presenting symptom. Inour 
report, headache was a prominent 
presenting symptom which is in keeping 
with other reports. The neurologic 
manifestations such as syncope, dizziness, 
seizure and cranial nerve deficits are 
present in 40% of primary ESS patients, and 
this is consistent with the of our patient's 
presentation with syncopal attack without a 
known aetiology.
De Marinis et al reported that half of the 
patients with Primary ESS have endocrine 
abnormalities. Additionally, a systematic 
review conducted by Auer et al reported a 
52% prevalence of hormonal deficiencies in 
patients with primary ESS.They further 
found that multiple hormonal deficiencies 
are more frequent with a prevalence of 30% 
as compared to isolated hypopituitarism 
occurring in 21% of the PES cases, and 
growth hormone being the most frequently 
affected followed by gonadotropins. 
Secondary hypoadrenalism is another 
common complication of primary ESS. 
Although our patient had decreased 
random cortisol levels, clinical and 
biochemical parameters were not in 
keeping with hypocortisolism underscoring 
the importance of dynamic test when 
secondary hypoadrenalism is suspected. 
The possible mechanisms underlying 
pituitary hypofunction in primary ESS 
include a direct compression of the pituitary 
gland against the sella and pituitary stalk 
disturbance.
Conclusion
Primary empty sella syndrome is rare in our 
endocrine practice possibly due to the low 
rate of advanced neuroimaging in a low-
resource setting like ours. A high index of 
suspicion for primary ESS is required in a 
morbidly obese middle-aged woman 
presenting with headache and syncopal 
attack. This may provide an opportunity to 
unravel an underlying hormonal deficiency 
as a potential complication of primary ESS.
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